美国 · SEC FORM 4
LENSAR, Inc.
LNSR · Nasdaq · CIK 0001320350 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
0 sales · 14 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-09-03 · Winer Gary M.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 322,414
- 上期报告
- 338,227
- 日均成交量
- 49,077
- 回补天数
- 6.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-09-03 | Winer Gary M | 买入 (P) | Common Stock | 685 | USD 4.50 | USD 3,082 | SEC 申报 ↗ |
| 2024-08-28 | Winer Gary M | 买入 (P) | Common Stock | 1,000 | USD 4.45 | USD 4,450 | SEC 申报 ↗ |
| 2024-08-27 | Winer Gary M | 买入 (P) | Common Stock | 500 | USD 4.50 | USD 2,250 | SEC 申报 ↗ |
| 2024-08-26 | Winer Gary M | 买入 (P) | Common Stock | 802 | USD 4.58 | USD 3,673 | SEC 申报 ↗ |
| 2024-08-22 | Winer Gary M | 买入 (P) | Common Stock | 2 | USD 4.30 | USD 9 | SEC 申报 ↗ |
| 2024-08-21 | Winer Gary M | 买入 (P) | Common Stock | 500 | USD 4.35 | USD 2,175 | SEC 申报 ↗ |
| 2024-08-20 | Winer Gary M | 买入 (P) | Common Stock | 500 | USD 4.20 | USD 2,100 | SEC 申报 ↗ |
| 2024-08-16 | Winer Gary M | 买入 (P) | Common Stock | 6 | USD 4.03 | USD 24 | SEC 申报 ↗ |
| 2024-08-14 | Winer Gary M | 买入 (P) | Common Stock | 1,000 | USD 4.20 | USD 4,200 | SEC 申报 ↗ |
| 2024-08-12 | Winer Gary M | 买入 (P) | Common Stock | 500 | USD 4.03 | USD 2,015 | SEC 申报 ↗ |
| 2023-11-22 | Winer Gary M | 买入 (P) | Common Stock | 300 | USD 2.10 | USD 630 | SEC 申报 ↗ |
| 2023-11-16 | Winer Gary M | 买入 (P) | Common Stock | 1,000 | USD 2.13 | USD 2,130 | SEC 申报 ↗ |
| 2023-11-15 | Winer Gary M | 买入 (P) | Common Stock | 500 | USD 2.15 | USD 1,075 | SEC 申报 ↗ |
| 2023-11-10 | Winer Gary M | 买入 (P) | Common Stock | 1,000 | USD 2.14 | USD 2,140 | SEC 申报 ↗ |
| 2023-08-11 | Winer Gary M | 买入 (P) | Common Stock | 705 | USD 3.60 | USD 2,538 | SEC 申报 ↗ |
Form 4 申报证据
21 transaction lines in the latest 365-day window; 107 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Wong Kendra | 奖励／授予 (A) | Common Stock | 13,066 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | Winer Gary M | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | WEISNER AIMEE S | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (21 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Wong Kendra | 奖励／授予 (A) | Common Stock | 13,066 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | Winer Gary M | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | WEISNER AIMEE S | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | O'Farrell Elizabeth G. | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | LINK WILLIAM J PHD | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | LINDSTROM RICHARD L MD | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | HAMMER TODD B | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | ELLIS THOMAS B | 奖励／授予 (A) | Common Stock | 17,421 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | Connaughton Alan B. | 奖励／授予 (A) | Common Stock | 34,843 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | CURTIS NICHOLAS T | 奖励／授予 (A) | Common Stock | 130,662 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Wong Kendra | 代扣税 (F) | Common Stock | 864 | USD 5.39 | USD 4,657 | SEC 申报 ↗ |
| 2026-05-06 | STAAB THOMAS R II | 代扣税 (F) | Common Stock | 1,350 | USD 5.39 | USD 7,276 | SEC 申报 ↗ |
| 2026-05-06 | Connaughton Alan B. | 代扣税 (F) | Common Stock | 2,739 | USD 5.39 | USD 14,763 | SEC 申报 ↗ |
| 2026-05-06 | CURTIS NICHOLAS T | J (J) | Common Stock | — | USD — | USD — | SEC 申报 ↗ |
| 2026-03-19 | STAAB THOMAS R II | 期权行权／转换 (M) | Common Stock | 5,500 | USD 2.65 | USD 14,575 | SEC 申报 ↗ |
| 2026-02-18 | STAAB THOMAS R II | 代扣税 (F) | Common Stock | 1,076 | USD 11.32 | USD 12,180 | SEC 申报 ↗ |
| 2026-02-18 | Connaughton Alan B. | 代扣税 (F) | Common Stock | 2,392 | USD 11.32 | USD 27,077 | SEC 申报 ↗ |
| 2026-02-18 | CURTIS NICHOLAS T | J (J) | Common Stock | — | USD — | USD — | SEC 申报 ↗ |
| 2026-01-11 | STAAB THOMAS R II | 代扣税 (F) | Common Stock | 1,826 | USD 11.57 | USD 21,127 | SEC 申报 ↗ |
| 2026-01-11 | Connaughton Alan B. | 代扣税 (F) | Common Stock | 2,262 | USD 11.57 | USD 26,171 | SEC 申报 ↗ |
| 2026-01-11 | CURTIS NICHOLAS T | J (J) | Common Stock | — | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LNSR |
| CIK | 0001320350 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 107 transaction lines from 2020-09-29 to 2026-06-03 30 P purchase lines · 0 S sale lines · 77 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.